ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had revenue of $33.66M in the quarter ending June 30, 2026, with 114.15% growth. This brings the company's total for the last twelve months to $116.93M, up 4.08% year-over-year. In the year 2025, ARS Pharmaceuticals had annual revenue of $84.28M, down -5.46%. That makes ARS Pharmaceuticals the 21,477th largest company in the world by revenue and 3,188th in the United States.

• Revenue (ttm): $116.93M
• Revenue Growth: +4.08%
• P/S Ratio: 3.17
• Revenue / Employee: $584,635
• Employees: 200
• Market Cap: 370.94M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 72.19M 85.7%
• Rest of World 12.09M 14.3%

Fiscal year ended Dec 31, 2025 See the full ARS Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	84.28M	-4.87M	-5.46%
Dec 31, 2024	89.15M	89.12M	297,063.33%
Dec 31, 2023	30.00K	-1.29M	-97.72%
Dec 31, 2022	1.32M	-4.19M	-76.10%
Dec 31, 2021	5.51M	-12.33M	-69.13%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error